Angiochem crosses BBB, shows safety, efficacy in phase 1/2 brain cancer studies

Sunday, October 18, 2009 - 12:49 in Biology & Nature

Montreal, Canada, and Chicago, IL, October 19, 2009 -- Angiochem, Inc.

Read the whole article on Science Blog

More from Science Blog

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net